Search - tctmd.com

Displaying 61 - 80 of 87

Sort: Relevancy | Date

Presentation TCT 2017

Commentary II At What Point Does the Minimalist Strategy Become Ludicrous?

Presenter: Martin B. Leon

November 01, 2017

Presentation TCT 2017

Commentary I Insights From the 3M Trial

Presenter: David A. Wood

November 01, 2017

Presentation TCT 2017

Counterpoint A Customized Approach, Including General Anesthesia and TEE, Optimizes Patient Outcomes!

Presenter: Omar K. Khalique

November 01, 2017

Presentation TCT 2017

Point TAVR Without General Anesthesia and Without TEE is now the Default Strategy!

Presenter: Ganesh Manoharan

November 01, 2017

Presentation TCT 2017

Counterpoint Clinical Trial Results are Inconclusive and Systematic Use of Cerebral Protection During TVR is Unwarranted!

Presenter: Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Point A Balanced Look at ALL the Data Favors Cerebral Protection in ALL TAVR Patients!

Presenter: Saif Anwaruddin

November 01, 2017

News Conference News SCCT 2017

Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions

Yael L. Maxwell

July 08, 2017

Presentation TVT 2017

An Imaging Perspective of Leaflet Thickening on MDCT: Lessons Learned and Next Steps

Presenter: Martin B. Leon, Hendrik Treede, Philipp Blanke

June 16, 2017

Presentation TVT 2017

Featured Lecture: The Spectrum of Bioprosthetic Valve Leaflet Thrombosis: From "Subclinical" Leaflet Thickening to Hemodynamic Changes and Clinical Events

Presenter: David W.M. Muller, Lars Sondergaard

June 16, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

News Daily News

Leaflet Thickening, Valve Durability After Balloon-Expandable TAVR: Studies Offer New Insights

Todd Neale

December 26, 2016

Presentation TCT 2016

Flash Debate: Point 4D-CT Leaflet Thickening Is an Imaging Curiosity With No Clinical Relevance!

Presenter: Raj Makkar, Lars Sondergaard, Ganesh Manoharan

October 31, 2016

Presentation TCT 2016

Controversy 2. Global Clinical Trial Experiences on Bioprosthetic Leaflet Thickening/Thrombosis: Updates and Insights

Presenter: Raj Makkar, Lars Sondergaard

October 31, 2016

Presentation TCT 2016

Leaflet Thickening, Dysfunction, and Thrombosis: Clinical Perspectives- Are Problems Under-Reported? Are the Changes a Class Effect?

Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Raj Makkar

October 30, 2016

Presentation TCT 2016

Leaflet Thickening, Dysfunction, and Thrombosis: Latest Recommendations by the ISO Cardiac Valves Committee

Presenter: Carlos E. Ruiz, Ulrich Steinseifer

October 30, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shelley Wood

September 20, 2016

News Conference News PCR London Valves 2016

Leaflet Restriction After TAVR: Two Hospitals Tracking Patients Find Similar Rates of the Phenomenon

Shelley Wood

September 20, 2016

News Conference News ESC 2016

Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy

Todd Neale

September 02, 2016

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

Advertisement

Commentary II At What Point Does the Minimalist Strategy Become Ludicrous?

Commentary I Insights From the 3M Trial

Counterpoint A Customized Approach, Including General Anesthesia and TEE, Optimizes Patient Outcomes!

Point TAVR Without General Anesthesia and Without TEE is now the Default Strategy!

Counterpoint Clinical Trial Results are Inconclusive and Systematic Use of Cerebral Protection During TVR is Unwarranted!

Point A Balanced Look at ALL the Data Favors Cerebral Protection in ALL TAVR Patients!

Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions

An Imaging Perspective of Leaflet Thickening on MDCT: Lessons Learned and Next Steps

Featured Lecture: The Spectrum of Bioprosthetic Valve Leaflet Thrombosis: From "Subclinical" Leaflet Thickening to Hemodynamic Changes and Clinical Events

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Leaflet Thickening, Valve Durability After Balloon-Expandable TAVR: Studies Offer New Insights

Flash Debate: Point 4D-CT Leaflet Thickening Is an Imaging Curiosity With No Clinical Relevance!

Controversy 2. Global Clinical Trial Experiences on Bioprosthetic Leaflet Thickening/Thrombosis: Updates and Insights

Leaflet Thickening, Dysfunction, and Thrombosis: Clinical Perspectives- Are Problems Under-Reported? Are the Changes a Class Effect?

Leaflet Thickening, Dysfunction, and Thrombosis: Latest Recommendations by the ISO Cardiac Valves Committee

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Leaflet Restriction After TAVR: Two Hospitals Tracking Patients Find Similar Rates of the Phenomenon

Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content